These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. The recent advances of phenotypes in acute exacerbations of COPD. Zhou A; Zhou Z; Zhao Y; Chen P Int J Chron Obstruct Pulmon Dis; 2017; 12():1009-1018. PubMed ID: 28392685 [TBL] [Abstract][Full Text] [Related]
47. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390 [TBL] [Abstract][Full Text] [Related]
48. [Non-pharmacological management in acute COPD exacerbations]. Gonzalez-Bermejo J; Guerder A; Reychler G Rev Mal Respir; 2017 Apr; 34(4):477-486. PubMed ID: 28495297 [No Abstract] [Full Text] [Related]
49. Predictive value of platelet-to-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease. Karadeniz G; Aktoğu S; Erer OF; Kır SB; Doruk S; Demir M; Sonat K Biomark Med; 2016 Jul; 10(7):701-10. PubMed ID: 27339097 [TBL] [Abstract][Full Text] [Related]
50. The concept of control of COPD in clinical practice. Soler-Cataluña JJ; Alcázar-Navarrete B; Miravitlles M Int J Chron Obstruct Pulmon Dis; 2014; 9():1397-405. PubMed ID: 25548521 [TBL] [Abstract][Full Text] [Related]
51. Predictors of hospital admission in exacerbations of chronic obstructive pulmonary disease. Vidal S; González N; Barrio I; Rivas-Ruiz F; Baré M; Blasco JA; Ruíz-Frutos C; Quintana JM; Int J Tuberc Lung Dis; 2013 Dec; 17(12):1632-7. PubMed ID: 24200281 [TBL] [Abstract][Full Text] [Related]
53. Guideline for the management of chronic obstructive pulmonary disease (COPD): 2004 revision. Bateman ED; Feldman C; O'Brien J; Plit M; Joubert JR; S Afr Med J; 2004 Jul; 94(7 Pt 2):559-75. PubMed ID: 15283307 [TBL] [Abstract][Full Text] [Related]
54. Development of a nomogram for predicting in-hospital mortality of patients with exacerbation of chronic obstructive pulmonary disease. Sakamoto Y; Yamauchi Y; Yasunaga H; Takeshima H; Hasegawa W; Jo T; Sasabuchi Y; Matsui H; Fushimi K; Nagase T Int J Chron Obstruct Pulmon Dis; 2017; 12():1605-1611. PubMed ID: 28615933 [TBL] [Abstract][Full Text] [Related]
55. Walking towards personalized medicine in pulmonary rehabilitation: Comorbidities and COPD. Evans RA Chron Respir Dis; 2016 Aug; 13(3):284-5. PubMed ID: 27488126 [No Abstract] [Full Text] [Related]
56. [Asthma COPD Overlap Syndrome (ACOS): precision medicine or diagnostic dead end?]. Taube C Dtsch Med Wochenschr; 2016 Sep; 141(18):1283. PubMed ID: 27598912 [No Abstract] [Full Text] [Related]
57. Acute exacerbations of COPD: the challenge is early treatment. Seemungal TA; Wedzicha JA COPD; 2009 Apr; 6(2):79-81. PubMed ID: 19378218 [No Abstract] [Full Text] [Related]
58. Exacerbations of Chronic Obstructive Pulmonary Disease and Quality of Life of Patients. Rubinsztajn R; Przybyłowski T; Maskey-Warzechowska M; Karwat K; Chazan R Adv Exp Med Biol; 2016; 884():69-74. PubMed ID: 26542597 [TBL] [Abstract][Full Text] [Related]
59. Lung Disease and Genomics. Wysocki K AACN Adv Crit Care; 2018; 29(1):74-83. PubMed ID: 29496715 [TBL] [Abstract][Full Text] [Related]
60. Precision Medicine Urgency: The Case of Inhaled Corticosteroids in COPD. Suissa S; Ernst P Chest; 2017 Aug; 152(2):227-231. PubMed ID: 28797382 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]